Jessica Mega of Verily Discusses AI in Healthcare
Q: Artificial intelligence (AI) techniques have sent vast waves across healthcare, even fueling an active discussion of whether AI doctors will eventually replace human physicians in the future. Do you believe that human physicians will be replaced by machines in the foreseeable future? What are your thoughts?
A: In addition to the science, the art of medical practice is a critical dimension of patient care and that part of the human experience can’t easily be replaced by AI.
read moreInterview Questions For Gertjan Bartlema of Celularity, Inc.
Q: Artificial intelligence (AI) techniques have sent vast waves across healthcare, even fueling an active discussion of whether AI doctors will eventually replace human physicians in the future. Do you believe that human physicians will be replaced by machines in the foreseeable future? What are your thoughts?
A: In my opinion, physicians will not be replaced by machines in the foreseeable future.
read moreInterview with Daphne Koller of Insitro
Q: What need is Insitro addressing?
A: Despite the marvels and triumphs of modern medicine many diseases remain untreatable. And the development of novel therapeutics to address these conditions isn’t getting any easier or cheaper, with clinical trial success rates hovering in the single-digits and the capitalized R&D spend per approved drug estimated at $2.5B.
read moreInterview with Daniel Chen of IGM Biosciences
Q: Checkpoint inhibitors, particularly with PD-L1/PD-1 targeting agents, have benefited a broad range of patients with cancer. How will we improve on this?
A: It’s true that PD-L1/PD-1 inhibitors have led to durable responses in a subset of patients, and survival benefit in many of the patients treated- either as monotherapy or combination.
read moreCall from PMWC 2019 Silicon Valley Program Committee – We Must Accelerate and Deliver on the Promise of Precision Medicine
Precision medicine advancements are real as demonstrated by the high volume of molecular, “precise” drugs on the market, which are based on extensive molecular and translational understanding of the specific drug targets.
read more#AI Play in Patient Diagnosis? How Can We Prepare the Next Generation to Make Sense of Enormous Amounts of Health-related Data?
What role should artificial intelligence play in patient diagnosis? How can we best prepare the next generation to make sense of enormous amounts of health-related data? These were just a few of the questions explored at the 15th Precision Medicine World Conference held at Duke University September 24-25, 2018.
read moreInterview with Daniella Beller, Manager, Maccabi Research Institute Biobank
Q: What makes the Maccabi Research Institute biobank unique?
A: To explain the uniqueness of the Maccabi Biobank (named “Tipa” in Hebrew which means “drop” or “just a little”), first you must know a little about Maccabi.
read moreWhy We Need Public-Private Partnerships (PPP) To Foster Drug Discovery
Investments in pharma R&D has substantially increased over the last decades. Yet there appears to be no clear correlation to the number of newly approved drugs. This fact is accompanied by ever-increasing healthcare costs, fueled by an aging population and the parallel rise in the chronic disease burden.
read morePrecision Medicine: A Decade of Improving the Standard of Care
In January, PMWC will host its 2019 Silicon Valley event, the largest Precision Medicine conference in the world with over 2,500 attendees gathering at the Santa Clara Convention Center. We are humbled and honored to have reached this stage of growth and are looking forward to continuing our work with key stakeholders and decision makers across the industry to ever strengthen this forum for exchange of critical and timely topics, to move the field of precision medicine forward and to improve the Standard of Care.
read moreInterview with David Hong of Karius
Q: What need is Karius addressing?
A: Physicians often have difficulty pinpointing the exact pathogen that is causing disease. Conventional diagnostics like blood cultures or PCR can have poor sensitivity due to pretreatment with antibiotics, the breadth of potential pathogens present, and the requirement for invasive procedures to access deep-seated infections.
read more
